Celgene Corp
CELG
CELG was delisted on the 20th of November, 2019.
1,364 hedge funds and large institutions have $46.6B invested in Celgene Corp in 2018 Q3 according to their latest regulatory filings, with 107 funds opening new positions, 487 increasing their positions, 565 reducing their positions, and 93 closing their positions.
15% more first-time investments, than exits
New positions opened: 107 | Existing positions closed: 93
8% more capital invested
Capital invested by funds: $43.1B → $46.6B (+$3.56B)
0% more funds holding
Funds holding: 1,360 → 1,364 (+4)
5% less funds holding in top 10
Funds holding in top 10: 39 → 37 (-2)
14% less repeat investments, than reductions
Existing positions increased: 487 | Existing positions reduced: 565
20% less call options, than puts
Call options by funds: $1.39B | Put options by funds: $1.75B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$585M |
| 2 |
Jennison Associates
New York
|
+$243M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$187M |
| 4 |
Edgewood Management
Greenwich,
Connecticut
|
+$162M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$123M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HI
HBK Investments
Dallas,
Texas
|
-$1.37B |
| 2 |
Renaissance Technologies
New York
|
-$228M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$181M |
| 4 |
BlackRock
New York
|
-$149M |
| 5 |
Swedbank
Stockholm,
Sweden
|
-$137M |
CELG Hedge Fund Activity: Q3 2018 in Review
1,364 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q3 2018, worth a combined $46.6B — up 8.3% from $43.1B a quarter earlier.
Buyers outnumbered sellers: 107 funds opened new CELG positions and 93 closed out — a net gain of 14 holders — while 487 added to existing stakes and 565 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $585M. The largest seller was HBK Investments, exiting entirely with an estimated $1.37B sold.
- 1,364 institutional investors held Celgene Corp (CELG) as of Q3 2018, up from 1,360 in Q2 2018.
- Funds reported $46.6B of Celgene Corp stock for Q3 2018, up 8.3% quarter-over-quarter.
- 107 funds opened new Celgene Corp positions in Q3 2018 and 93 closed out, a net change of +14 holders.
- The largest Celgene Corp buyer in Q3 2018 was T. Rowe Price Associates, an estimated $585M added.
- The largest Celgene Corp seller in Q3 2018 was HBK Investments, an estimated $1.37B sold.
Based on aggregated 13F filings for Q3 2018.